BIO LINE, UAB - financials and debts

Company age: 17 y. 4 mo.

Update

BIO LINE - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 52,191 53,529 42,330 48,116 53,114 50,334 51,480 50,609
Profit before tax - - -3,595 63,573 - - - -
Net profit 4,383 6,273 -3,595 62,086 7,138 989 3,845 2,479
Equity -15,886 -9,613 -13,208 118,238 125,082 126,071 129,917 118,523
Liabilities 238,782 218,003 193,072 159,176 158,073 137,982 135,158 136,595
Non-current assets 190,663 171,740 152,816 171,583 267,973 225,974 217,234 230,779
Current assets 23,062 27,479 17,877 96,926 6,693 29,284 38,928 23,667
Total assets 213,725 199,219 170,693 268,509 274,666 255,258 256,162 254,446
Taxes paid
STI taxes - - - - - 9,721 9,691 8,515
Financial indicators
Revenue change y/y +11.5% +2.6% -20.9% +13.7% +10.4% -5.2% +2.3% -1.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 2.1% 3.1% -2.1% 23.1% 2.6% 0.4% 1.5% 1.0%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - 52.5% 5.7% 0.8% 3.0% 2.1%
Profit margin Net profit margin. Shows the overall profitability of the company. 8.4% 11.7% -8.5% 129.0% 13.4% 2.0% 7.5% 4.9%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - -8.5% 132.1% - - - -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - 1.3 1.3 1.1 1.0 1.2
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 52,191 53,529 42,330 48,116 53,114 50,334 51,480 50,609

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

BIO LINE - Social security debts

From To Debt, €
2024-05-16 2024-06-04 0.13
2024-04-23 2024-05-07 16.59
2024-04-16 2024-04-22 16.46
2024-02-19 2024-03-12 16.46
2023-10-27 2023-11-14 0.16
2023-10-25 2023-10-25 0.16
2023-05-16 2023-06-13 0.34
2023-05-02 2023-05-03 0.34
2023-04-25 2023-04-28 0.34
2023-01-17 2023-01-22 174.81
2022-04-25 2022-05-02 0.42
2022-02-22 2022-02-22 14.55
2022-02-17 2022-02-21 174.84

BIO LINE - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
BIO LINE, UAB (code 302337528) is a Private Limited Liability Company engaged in the rental and operating of own or leased real estate. In 2025, the company generated revenue of €50.6K, slightly below the €51.5K recorded in 2024 and broadly in line with €50.3K in 2023. Net profit for 2025 was €2.5K, compared with €3.8K in 2024 and €989 in 2023, showing positive but fluctuating profitability over the three-year period. The profit margin was 4.9% in 2025, after 7.5% in 2024 and 2.0% in 2023. Balance sheet indicators remained stable: total assets were €254.4K in 2025, equity €118.5K and liabilities €136.6K. Long-term assets accounted for most of the asset base at €230.8K, while short-term assets stood at €23.7K. Key ratios for 2025 show a moderate equity ratio of 46.6%, debt-to-equity of 1.15, ROE of 2.1%, ROA of 1.0%, and asset turnover of 0.20x. Revenue per employee was €50.6K and profit per employee €2.5K.